MENU
APR 21, 2020 1:30 PM PDT

Spatially Resolved Molecular Investigation of Triple Negative Breast Cancer

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Product Manager, 10x Genomics
    Biography
      Dina Finan is a Product Manager at 10x Genomics. Prior to joining 10x, she worked in the field of protein engineering and antibody stability. She received a Ph.D. in Biochemistry at Stanford University studying molecular motor proteins and their role in embryonic development.
    • Senior Computational Biologist, 10x Genomics
      Biography
        Stephen Williams is a Senior Computational Biologist at 10x Genomics. Prior to joining 10x Genomics, she was an Assistant Professor at University of Virginia. He received a Ph.D. in Human and Molecular Genetics at Virginia Commonwealth University where he studied the genomic and molecular causes of intellectual disability syndromes such as Smith-Magenis Syndrome.

      Abstract

      Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for 10-20% of all breast cancer cases diagnosed annually in the U.S.1. Despite its prevalence, TNBC remains resistant to conventional therapies, leading to a poor prognosis. The lack of therapeutic targets, as well as the complexity of the disease, make it critical to further investigate the underlying biology in order to improve diagnosis and therapeutic outcome. Spatial transcriptomics technology has helped address the limitations of traditional pathology examination, by combining the benefits of histology and massive throughput of RNA-seq. We investigated serial sections of TNBC2, using the 10x Genomics Visium Spatial Gene Expression Solution, to resolve its tumorigenic expression profile. This assay incorporates ~5000 molecularly barcoded, spatially encoded capture probes in spots over which tissue is placed, imaged, and permeabilized, capturing native mRNA in an unbiased fashion. Imaging and NGS data are processed together resulting in gene expression mapped to image position. We demonstrated spatial patterns of gene expression that agreed with annotations from pathological examination. This was then combined with immunohistochemical staining for tumor infiltrating lymphocytes, a hallmark of TNBC. By aggregating data from serial sections, we improved the delineation of gene expression patterns and demonstrate improved statistical power for cell-type identification. We combined these data with 3’ single-nucleus RNA-seq from the same sample, generating cell-type expression profiles that were used to annotate cell-types observed at a given position. Finally, we used an enrichment strategy to select for cancer-associated genes and show concordance with the full transcriptome assay, suggesting that a targeted sequencing approach can be used where a fixed gene panel is appropriate. Results from these efforts suggest that spatial gene expression profiling can provide a powerful complement to traditional histopathology, enabling both targeted panels and whole-transcriptome discovery of gene expression. This detailed view of the tumor microenvironment, as it varies across the tissue space, provides essential insight into disease understanding and the development of potential new therapeutic targets.

      Learning Objectives:

      1. Understand the value of the Visium Spatial Gene Expression Solution and how it works

      2.Explore how 10x Genomics products work together to provide insight into biology at resolution and scale

      3. Learn how 3rd party tools, in combination with the Visium spatial gene expression technology, capture the power of new methods and algorithm


      Show Resources
      You May Also Like
      OCT 08, 2020 7:00 AM PDT
      C.E. CREDITS
      OCT 08, 2020 7:00 AM PDT
      DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
      NOV 16, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      SEP 02, 2020 7:00 AM PDT
      C.E. CREDITS
      SEP 02, 2020 7:00 AM PDT
      DATE: September 2, 2020 TIME: 03:00pm PDT, 6:00pm EDT Spatial omics is an expanding collection of methods to examine biological molecules in their geographical context. By retaining the prec...
      AUG 25, 2020 8:00 AM PDT
      C.E. CREDITS
      AUG 25, 2020 8:00 AM PDT
      DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
      MAY 08, 2020 10:00 AM PDT
      C.E. CREDITS
      MAY 08, 2020 10:00 AM PDT
      DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
      Loading Comments...
      Show Resources